Filing Details
- Accession Number:
- 0001127602-20-030339
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-02 17:45:44
- Reporting Period:
- 2020-12-01
- Accepted Time:
- 2020-12-02 17:45:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc. | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1520943 | A Francis Desouza | 5200 Illumina Way San Diego CA 92122 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-12-01 | 561 | $323.83 | 60,979 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-12-01 | 142 | $324.61 | 60,837 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-12-01 | 225 | $325.79 | 60,612 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-12-01 | 190 | $326.76 | 60,422 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-12-01 | 348 | $327.97 | 60,074 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-12-01 | 851 | $329.02 | 59,223 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-12-01 | 218 | $329.73 | 59,005 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-12-01 | 52 | $331.01 | 58,953 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-12-01 | 361 | $332.78 | 58,592 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-12-01 | 52 | $333.53 | 58,540 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 561 shares sold ranging from $323.32 to $324.20 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 142 shares sold ranging from $324.33 to $325.06 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.Cancel
- Weighted average sale price representing 225 shares sold ranging from $325.34 to $326.15 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 190 shares sold ranging from $326.39 to $327.32 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 348 shares sold ranging from $327.42 to $328.42 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 851 shares sold ranging from $328.45 to $329.43 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 218 shares sold ranging from $329.48 to $330.12 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 361 shares sold ranging from $332.26 to $333.26 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.